Literature DB >> 4016708

Do regular ovulatory cycles increase breast cancer risk?

B E Henderson, R K Ross, H L Judd, M D Krailo, M C Pike.   

Abstract

The "estrogen window hypothesis" of the etiology of breast cancer proposes that unopposed estrogen stimulation is the most favorable state for tumor induction and that normal postovulation progesterone secretion reduces susceptibility. The authors believe that epidemiologic and experimental studies suggest rather that the opposite is true, i.e., that breast cancer risk is directly related to the cumulative number of regular ovulatory cycles. Unlike the endometrium, breast tissue mitotic activity is enhanced in the luteal phase of the menstrual cycle. Regular vigorous physical activity is one method of reducing the frequency of ovulatory cycles, and such exercise could markedly reduce a woman's lifetime risk of developing breast cancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016708     DOI: 10.1002/1097-0142(19850901)56:5<1206::aid-cncr2820560541>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  72 in total

1.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

Authors:  F Clavel-Chapelon
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

Review 2.  Epidemiologic perspective on immune-surveillance in cancer.

Authors:  Daniel W Cramer; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

3.  A case-control study of menstrual factors in relation to breast cancer risk in African-American women.

Authors:  Jessica S B Beiler; Kangmin Zhu; Sandra Hunter; Kathleen Payne-Wilks; Chanel L Roland; Vernon M Chinchilli
Journal:  J Natl Med Assoc       Date:  2003-10       Impact factor: 1.798

4.  Unraveling genes, hormones, and breast cancer.

Authors:  Jonine D Figueroa; Louise A Brinton
Journal:  J Natl Cancer Inst       Date:  2012-04-03       Impact factor: 13.506

5.  A case-control study of body mass index and breast cancer risk in white and African-American women.

Authors:  Paula Berstad; Ralph J Coates; Leslie Bernstein; Suzanne G Folger; Kathleen E Malone; Polly A Marchbanks; Linda K Weiss; Jonathan M Liff; Jill A McDonald; Brian L Strom; Michael S Simon; Dennis Deapen; Michael F Press; Ronald T Burkman; Robert Spirtas; Giske Ursin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

6.  Differences in ovarian hormones in relation to parity and time since last birth.

Authors:  Emily S Barrett; Lauren E Parlett; Gayle C Windham; Shanna H Swan
Journal:  Fertil Steril       Date:  2014-03-28       Impact factor: 7.329

Review 7.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

8.  Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers.

Authors:  Shana J Kim; Tomasz Huzarski; Jacek Gronwald; Christian F Singer; Pål Møller; Henry T Lynch; Susan Armel; Beth Y Karlan; William D Foulkes; Susan L Neuhausen; Leigha Senter; Andrea Eisen; Charis Eng; Seema Panchal; Tuya Pal; Olufunmilayo Olopade; Dana Zakalik; Jan Lubinski; Steven A Narod; Joanne Kotsopoulos
Journal:  Int J Epidemiol       Date:  2018-06-01       Impact factor: 7.196

9.  Breastfeeding and breast cancer risk.

Authors:  L A Brinton; N A Potischman; C A Swanson; J B Schoenberg; R J Coates; M D Gammon; K E Malone; J L Stanford; J R Daling
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

Review 10.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.